In a filing, Cognition Therapeutics Inc revealed its CEO & President Ricciardi Lisa acquired Company’s shares for reported $9975.0 on Mar 14 ’24. In the deal valued at $1.75 per share,5,700 shares were bought. As a result of this transaction, Ricciardi Lisa now holds 291,345 shares worth roughly $0.18 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cantor Fitzgerald downgraded its Cognition Therapeutics Inc [CGTX] rating to a Neutral from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in early November with a ‘”an Outperform”‘ rating. B. Riley Securities began covering CGTX with “Buy” recommendation on November 03, 2021.
Price Performance Review of CGTX
On Tuesday, Cognition Therapeutics Inc [NASDAQ:CGTX] saw its stock jump 0.50% to $0.61. Over the last five days, the stock has lost -4.18%. Cognition Therapeutics Inc shares have fallen nearly -67.16% since the year began. Nevertheless, the stocks have fallen -59.50% over the past one year. While a 52-week high of $2.95 was reached on 05/23/24, a 52-week low of $0.54 was recorded on 08/09/24. SMA at 50 days reached $1.1696, while 200 days put it at $1.7520.
Levels Of Support And Resistance For CGTX Stock
The 24-hour chart illustrates a support level at 0.5896, which if violated will result in even more drops to 0.5717. On the upside, there is a resistance level at 0.6227. A further resistance level may holdings at 0.6379. The Relative Strength Index (RSI) on the 14-day chart is 33.80, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0773, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.70%. Stochastics %K at 13.07% indicates the stock is a buying.
How much short interest is there in Cognition Therapeutics Inc?
A steep rise in short interest was recorded in Cognition Therapeutics Inc stocks on 2024-08-15, growing by 0.43 million shares to a total of 0.65 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 0.21 million shares. There was a rise of 66.82%, which implies that there is a positive sentiment for the stock.
